Skip to main content
logo
SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.95
-0.05 (-0.25%)
Aug 26, 2026, 12:14 PM CST

TPEX:4192 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
26.2427.0423.3420.215.866.94
Revenue Growth
4.63%15.88%15.55%27.36%128.52%-47.97%
Gross Profit
21.3621.0912.890.529.092.97
Operating Income
-48.84-47.2-57.76-45.5-191.47-458.62
Net Income
-46.85-45.76-54.28-38.17-188.67-458.6
Earnings Per Share
-1.33-1.30-1.54-1.19-6.14-15.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
145.8164.41212.44271.36275.81559.63
Total Debt
12.531.957.791.9571.2125.3
Net Cash (Debt)
133.28162.46204.66269.4204.6434.34
Net Cash Growth
-26.61%-20.62%-24.03%31.67%-52.89%36.84%
Net Cash Per Share
3.794.625.828.406.6514.31

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-32.27-38.33-49.24-82.37-209.61-229.86
Capital Expenditures
-0.22-0.23-0.21-0.42-0.14-0.29
Free Cash Flow
-32.49-38.57-49.45-82.79-209.75-230.15
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
81.41%77.98%55.22%2.58%57.30%42.79%
Operating Margin
-186.15%-174.52%-247.49%-225.30%-1207.50%-6609.30%
Pretax Margin
-178.54%-169.19%-232.60%-189.01%-1189.80%-6608.98%
Profit Margin
-178.54%-169.19%-232.60%-189.01%-1189.80%-6608.98%
FCF Margin
-123.83%-142.61%-211.89%-409.92%-1322.74%-3316.73%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
26.7432.3852.5166.86184.33526.54